European Public/Private Initiative Plans $230M in Grants | GenomeWeb

NEW YORK (GenomeWeb News) – The Innovative Medicines Initiative, a research partnership between the European Commission and European pharmaceutical companies, will grant €156.3 million ($231.9 million) to researchers in its upcoming second funding call.

The IMI was created in 2007 to accelerate discovery and development of new drugs for cancer, inflammatory diseases, and infectious diseases by addressing important research bottlenecks in the process.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.